Estadisticas : Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study

Kahan, Z.
Visitas:865

480 ( Estados Unidos de América )

132 ( Singapur )

80 ( Reino Unido )

50 ( Hong kong )

34 ( Alemania )

25 ( Irlanda )

16 ( Letonia )

13 ( Brasil )

8 ( Austria )

4 ( Togo )

4 ( España )

3 ( Francia )

3 ( China )

2 ( Finlandia )

2 ( Canadá )

2 ( Sudáfrica )

2 ( Vietnam )

1 ( Bulgaria )

1 ( Ecuador )

1 ( Argentina )

1 ( Eslovenia )

1 ( Arabia Saudita )

Descargas: 328